[Combination chemotherapy with BH-AC, mitoxantrone, etoposide, and prednisolone to refractory or relapsed malignant lymphoma].
Satoh
T
T
First Dept. of Internal Medicine, Hirosaki University School of Medicine.
Tsushima
K
K
Hizawa
Y
Y
Nakui
Y
Y
Itoh
J
J
Tamura
Y
Y
Saitoh
S
S
Taka-mi
H
H
Munakata
A
A
Kawamura
S
S
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D016399:Lymphoma, T-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage
D003561:Cytarabine; D005047:Etoposide; D011239:Prednisolone; C015019:enocitabine; D008942:Mitoxantrone